Pharmaceutical Cos. to Remain in Suit
A judge Thursday refused to drop two pharmaceutical giants from scores of wrongful-death lawsuits stemming from the case of a pharmacist who watered down chemotherapy drugs given to cancer patients. Eli Lilly and Co. and Bristol-Myers Squibb argued that they were not liable for Robert Courtney's tampering with the drugs Gemzar and … [Read more...] about Pharmaceutical Cos. to Remain in Suit
Benicar Adverse Reactions
Benicar Adverse Drug Reactions. Lawsuits are mounting against drug maker, Daiichi Sankyo Inc., over claims that blood pressure medication, Benicar (olmesartan medoxomil), led to significant adverse reactions, including severe and chronic diarrhea, sprue-like enteropathy, weight loss, malnutrition, and intestinal atrophy. Forest … [Read more...] about Benicar Adverse Reactions
For Doctors, Relationships with Drug and Device Makers Raise Conflicts of Interest
Doctors Relationship With A Drug or Device Makers. The director of the leukemia program at the Cleveland Clinic, in a post for the New York Times' Well blog, doctors who have relationship with drug or device maker. Dr. Mikkael Sekeres used the example of his mother-in-law's hip replacement surgery to illustrate the … [Read more...] about For Doctors, Relationships with Drug and Device Makers Raise Conflicts of Interest
Takeda to Potentially Settle Actos Lawsuits for $2.2B
Reportedly, Takeda Pharmaceutical Co. has offered to settle more than 8,000 Actos lawsuits alleging the diabetes drug caused cancer for $2.2 billion; each case would receive about $275,000. Bloomberg reports that it would be one of the largest settlements in US history of patients lawsuits alleging injuries from drugs and medical … [Read more...] about Takeda to Potentially Settle Actos Lawsuits for $2.2B
Findings of Avandia Study Kept Under Wraps
Findings of Avandia Study Kept Under Wraps by Drug Maker. The maker of Avandia had evidence about the drug’s heart risks as early as 1999, but concealed that information from U.S. regulators and the public. According to a new report in The New York Times, SmithKline Beecham, now GlaxoSmithKline, began a study that year to … [Read more...] about Findings of Avandia Study Kept Under Wraps
FDA Rebukes Pfizer Over Geodon Study
Pfizer Over Geodon Study. The U.S. Food and Drug Administration (FDA) issued a warning to drug maker Pfizer Inc over a number of “failures” that resulted in overdoses in no less than 13 children, said Reuters. The overdoses occurred during Pfizer’s clinical trial of Geodon, an antipsychotic medication; the letter was made … [Read more...] about FDA Rebukes Pfizer Over Geodon Study
Seroquel Maker Discussed Promoting Off-Label Uses
Makers Of Seroquel Promote Off Label Uses. Lawyers for people suing Seroquel maker AstraZeneca will charge today that executives at the company discussed promoting the off-label use of the drug in children and elderly patients. Immediate demand Seroquel - which was introduced in 1997 - is approved to treat psychotic disorders, … [Read more...] about Seroquel Maker Discussed Promoting Off-Label Uses
More Questions About Emory University
Drug Maker On Its Faulty. Emory University is being criticized once again because of its financial ties to drug makers. This time, Senator Charles Grassley (R-Iowa) has slammed the Atlanta, GA university for allegedly changing its rules in order to protect a doctor who is on its faculty. Universities are supposed to monitor … [Read more...] about More Questions About Emory University
Merck & Co Follows Eli Lilly in Disclosing Physician Fees
Eli Lilly Disclosing Physician Fees. Earlier this week we reported that Eli Lilly and Company will reveal how much money it pays physicians for speeches and consulting, starting next year. Lilly was the first major drug maker to commit to physician payment disclosure, representing the newest example of the pharmaceutical industry's … [Read more...] about Merck & Co Follows Eli Lilly in Disclosing Physician Fees
Congress to Probe FDA Handling of Ranbaxy
FDA Handling of Ranbaxy. Members of Congress are getting ready to investigate the scandal surrounding generic drug maker Ranbaxy. The House Energy and Commerce Committee has scheduled a hearing to probe the Food and Drug Administration's (FDA) handling of allegations Ranbaxy sold potentially adulterated medicines. Based … [Read more...] about Congress to Probe FDA Handling of Ranbaxy
FDA Rebukes Glaxo for Avandia Study
The US Food and Drug Administration Federal (FDA) has just issued a warning to the drug maker, GlaxoSmithKline, for not reporting safety results on its diabetes pill Avandia. Avandia received the prominent, “Black Box” warning label last year and the FDA said that between 2001 and 2007 GlaxoSmithKline neglected to update the agency … [Read more...] about FDA Rebukes Glaxo for Avandia Study
Merck Scrapped Vioxx Study
Merck Scrapped Vioxx Study. Drug maker Merck & Co. scrapped a planned study of the cardiac safety of Vioxx once it knew U.S. regulators were going to tone down their warning about heart risks for patients taking the painkiller, a plaintiff's lawyer argued Friday in a product liability trial. But Merck's former head of U.S. … [Read more...] about Merck Scrapped Vioxx Study
Heart Failure Drug Maker Relays New Deaths
Heart Failure Drug Additional Deaths. The manufacturer of the heart failure drug Natrecor reported two additional deaths in patients involved in a study carried out three years ago but said it was confident the cases don't mean an increased risk. The deaths had not been previously reported to Natrecor's manufacturer, … [Read more...] about Heart Failure Drug Maker Relays New Deaths
Nearly $1.1B Bayer Settlements
Bayer Settlements Over Pulled Cholesterol Drug. Drug maker Bayer AG said Monday it has reached settlements in more than 2,800 cases related to the 2001 withdrawal of a cholesterol-lowering drug, paying nearly $1.1 billion in out-of-court deals. ‘Bayer’ pulled Lipobay, marketed as Baycol in the United States, after it was … [Read more...] about Nearly $1.1B Bayer Settlements
Drug Maker Withdraws Generic Nefazodone
Nefazodone May Cause Liver Damage. Health Canada announced Monday that generic versions of the antidepressant Serzone are also being pulled from the market. The department will oversee the withdrawal of all generic drugs containing nefazodone, the generic name for the drug marketed as Serzone. The drugs are being withdrawn because … [Read more...] about Drug Maker Withdraws Generic Nefazodone
Woman Sues Drug Maker, Pharmacy
Lawsuit Filed Against Drug Maker And Pharmacy. A Greenville woman who says she suffered a stroke from taking cold medicine five years ago filed a lawsuit Monday against the drug's manufacturer and the pharmacy that sold it to her. Sarah Taylor filed the suit Monday in the Greenville County Court of Common Pleas against … [Read more...] about Woman Sues Drug Maker, Pharmacy
Drug Maker Faces Ephedra Suit
Ephedra Supplement Has Been Linked To Bechler's Death. The company whose ephedra dietary supplement has been linked to the recent death of a Baltimore Orioles pitcher was sued Monday for false advertising by several California law enforcement agencies. The manufacturer of the ephedra product Xenadrine RFA-1 was named in a civil … [Read more...] about Drug Maker Faces Ephedra Suit
Family Suing Acne Drug Maker After Son’s Suicide
Acne Drug Maker Are Being Sued. The family of a 22-year-old Virginia man who committed suicide while taking the acne drug Accutane is suing the medicine's manufacturer and his dermatologist for $2.5 million. Nathan Day's parents, Willis Day and Marguerite Ziemba, filed an Accutane lawsuit Dec. 16 in Roanoke Circuit Court against … [Read more...] about Family Suing Acne Drug Maker After Son’s Suicide
Drug Maker to Pay $500M
Drug Maker Will Pay Record Fine. Drug maker Schering-Plough said Friday it will pay the federal government a record fine of at least $500 million because of quality-control violations at its New Jersey and Puerto Rico plants. The Food and Drug Administration said it was the biggest fine in the agency's history. It said FDA … [Read more...] about Drug Maker to Pay $500M
Jury Selection In Diet Drug Case
Diet Drug Can Cause Heart Problems. A woman who blames a popular diet drug combination for her heart trouble has gone to court to take on the world's seventh-largest drug maker in a closely watched case. Opening statements were expected to begin later today in the lawsuit filed in state district court by Sandra Moore against … [Read more...] about Jury Selection In Diet Drug Case
